Atlas Brown’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,339
| Closed | -$237K | – | 152 |
|
|
2020
Q1 | $237K | Sell |
1,339
-57
| -4% | -$10.7K | 0.19% | 125 |
|
|
2019
Q4 | $267K | Buy |
1,396
+24
| +2% | +$4.33K | 0.17% | 130 |
|
|
2019
Q3 | $231K | Sell |
1,372
-42
| -3% | -$6.84K | 0.16% | 131 |
|
|
2019
Q2 | $237K | Buy |
+1,414
| New | +$196K | 0.16% | 135 |
|
|
2019
Q1 | – | Sell |
-2,269
| Closed | -$303K | – | 151 |
|
|
2018
Q4 | $303K | Sell |
2,269
-880
| -28% | -$144K | 0.23% | 102 |
|
|
2018
Q3 | $600K | Buy |
3,149
+55
| +2% | +$10.1K | 0.37% | 79 |
|
|
2018
Q2 | $545K | Buy |
3,094
+189
| +7% | +$30.3K | 0.13% | 88 |
|
|
2018
Q1 | $489K | Sell |
2,905
-205
| -7% | -$34.4K | 0.09% | 87 |
|
|
2017
Q4 | $581K | Buy |
3,110
+229
| +8% | +$41.1K | 0.1% | 83 |
|
|
2017
Q3 | $590K | Buy |
2,881
+16
| +0.6% | +$3.72K | 0.13% | 71 |
|
|
2017
Q2 | $696K | Sell |
2,865
-65
| -2% | -$15.3K | 0.61% | 56 |
|
|
2017
Q1 | $700K | Sell |
2,930
-279
| -9% | -$65K | 0.55% | 57 |
|
|
2016
Q4 | $739K | Hold |
3,209
| – | – | 0.3% | 49 |
|
|
2016
Q3 | $739K | Hold |
3,209
| – | – | 0.3% | 49 |
|
|
2016
Q2 | $742K | Buy |
3,209
+1,152
| +56% | +$266K | 0.3% | 49 |
|
|
2016
Q1 | $551K | Hold |
2,057
| – | – | 0.23% | 55 |
|
|
2015
Q4 | $596K | Sell |
2,057
-115
| -5% | -$34.2K | 0.38% | 47 |
|
|
2015
Q3 | $590K | Hold |
2,172
| – | – | 0.25% | 49 |
|
|
2015
Q2 | $699K | Sell |
2,172
-381
| -15% | -$114K | 0.27% | 46 |
|
|
2015
Q1 | $760K | Buy |
+2,553
| New | +$728K | 0.2% | 42 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Atlas Brown's AGN Position: Q2 2020 in Review
Atlas Brown sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,339 shares — an estimated $237K sold.
Atlas Brown first reported a position in AGN in Q1 2015 and held it in 20 quarters. The position peaked at $760K in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Atlas Brown reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Atlas Brown sold 1,339 Allergan plc shares in Q2 2020, an estimated $237K.
- Atlas Brown first reported a position in Allergan plc in Q1 2015 and held it in 20 quarters.
- Atlas Brown's Allergan plc position peaked at $760K in Q1 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Atlas Brown's 13F filing for Q2 2020, filed 21 Jul 2020.